BIMI Holdings Inc.: Nasdaq/NYSE listing notice — BIMI receives Nasdaq non-compliance notice for late Q2 10-Q filing

BIMI Holdings Inc.

Nasdaq notified BIMI on Aug 22, 2023, that failure to file Form 10-Q for period ended June 30, 2023 violates Listing Rule 5250(c)(1).
Company has 60 calendar days to submit a plan to regain compliance; if accepted, Nasdaq may grant up to 180 days from due date to file.
If plan not accepted, BIMI may appeal to a Nasdaq hearings panel. No immediate effect on listing.
BIMI states it intends to resolve the deficiency and regain compliance.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BIMI Holdings Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

August 22, 2023, BIMI International Medical Inc. (the “Company”) received a notification letter (the “Nasdaq 10-Q Delinquency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Form 10-Q”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Nasdaq 10-Q Delinquency Letter states that t

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-23-070615

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.